
New pancreatic cancer drug offers hope
Daraxonrasib is the first drug in its class for adults with metastatic pancreatic adenocarcinoma, the most common type of pancreatic cancer.
The latest news and patient stories about Sharp Memorial Hospital from Sharp HealthCare experts and our Sharp Health News writers and contributors.

Our weekly email brings you the latest health tips, recipes and stories.